首页> 美国卫生研究院文献>Journal of Diabetes Investigation >Efficacy and safety of alogliptin added to sulfonylurea in Japanese patients with type 2 diabetes: A randomized double‐blind placebo‐controlled trial with an open‐label long‐term extension study

【2h】

Efficacy and safety of alogliptin added to sulfonylurea in Japanese patients with type 2 diabetes: A randomized double‐blind placebo‐controlled trial with an open‐label long‐term extension study

机译：在日本2型糖尿病患者中向磺酰脲类药物中加用阿格列汀的疗效和安全性：一项随机双盲安慰剂对照试验并进行长期开放性研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
引文网络
相似文献
相关主题

摘要

Aims/IntroductionTo evaluate the efficacy and safety of alogliptin added to treatment with glimepiride.

机译：目的/简介要评估在格列美脲治疗中添加的阿格列汀的疗效和安全性。

著录项

期刊名称 Journal of Diabetes Investigation
作者
Yutaka Seino; Shinzo Hiroi; Masashi Hirayama; Kohei Kaku;
展开▼
作者单位

展开▼
年(卷),期 2012(3),6
年度 2012
页码 517–525
总页数 9
原文格式 PDF
正文语种
中图分类基础医学;
关键词
Alogliptin Glimepiride Type 2 diabetes;

机译：阿格列汀;格列美脲;2型糖尿病;

相似文献

外文文献
中文文献

1. Efficacy and safety of alogliptin added to sulfonylurea in Japanese patients with type 2 diabetes: A randomized, double‐blind, placebo‐controlled trial with an open‐label, long‐term extension study [J] . Masashi Hirayama, Shinzo Hiroi, Yutaka Seino Journal of diabetes investigation. . 2012,第6期

机译：在日本2型糖尿病患者中向磺酰脲类药物中添加阿格列汀的疗效和安全性：一项随机，双盲，安慰剂对照试验，具有开放标签，长期扩展研究
2. Efficacy and safety of alogliptin added to sulfonylurea in Japanese patients with type 2 diabetes: A randomized, double‐blind, placebo‐controlled trial with an open‐label, long‐term extension study [J] . Masashi Hirayama, Shinzo Hiroi, Yutaka Seino Journal of diabetes investigation. . 2012,第6期

机译：在日本2型糖尿病患者中向磺酰脲类药物中添加阿格列汀的疗效和安全性：一项随机，双盲，安慰剂对照试验，具有开放标签，长期扩展研究
3. Efficacy and safety of alogliptin added to metformin in Japanese patients with type 2 diabetes: A randomized, double-blind, placebo-controlled trial with an open-label, long-term extension study [J] . SeinoY., MiyataY., HiroiS., Diabetes, obesity & metabolism . 2012,第10期

机译：阿格列汀加二甲双胍对日本2型糖尿病患者的疗效和安全性：一项随机，双盲，安慰剂对照试验，具有长期开放性标签研究
4. A DOUBLE-BLIND RANDOMIZED PLACEBO-CONTROLLED CLINICAL TRIAL TO INVESTIGATE THE EFFICACY OF TIAMULIN IN THE CONTROL OF PORCINE PROLIFERATIVE ENTEROPATHY (PPE) AND PORCINE COLONIC SPIROCHAETOSIS (PCS) UNDER FIELD CONDITIONS [C] . J. Haugegaard, K. Moller, T.K. Jensen, Congress of the International Pig Veterinary Society . 2000

机译：一种双盲随机安慰剂对照临床试验，探讨硫霉素在野生植物中猪增殖肠病（PPE）和猪结肠螺旋肌肤症（PCS）的疗效
5. Efficacy of the Chinese herbal formula CUF2 in the treatment of childhood asthma: Animal experiment, in vitro study and randomized, double-blinded, placebo-controlled clinical trial. [D] . Wong, Yeuk Oi. 2006

机译：中药配方CUF2在治疗儿童哮喘中的功效：动物实验，体外研究以及随机，双盲，安慰剂对照的临床试验。
6. Efficacy and safety of ipragliflozin as add-on therapy to insulin in Japanese patients with type 2 diabetes mellitus (IOLITE): a 36-week open-label extension of a 16-week randomized placebo-controlled double-blind study [O] . Hisamitsu Ishihara, Susumu Yamaguchi, Ikko Nakao, 2019

机译：依普列净作为日本2型糖尿病患者（IOLITE）胰岛素的附加疗法的有效性和安全性：一项为期16周随机安慰剂对照双盲研究的36周开放标签研究
7. Efficacy and safety of ipragliflozin as add-on therapy to insulin in Japanese patients with type 2 diabetes mellitus (IOLITE): a 36-week, open-label extension of a 16-week, randomized, placebo-controlled, double-blind study [O] . Hisamitsu Ishihara, Susumu Yamaguchi, Ikko Nakao, 2018

机译：IPragliflozin作为胰岛素的胰岛素患者的胰岛素的疗效和安全性患者（Iolite）：36周，开放式标签延伸16周，随机，安慰剂控制，双盲研究

Efficacy and safety of alogliptin added to sulfonylurea in Japanese patients with type 2 diabetes: A randomized double‐blind placebo‐controlled trial with an open‐label long‐term extension study

摘要

著录项

引文网络

相似文献

相关主题

期刊订阅